The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that aims to improve population health by connecting leaders and decision makers with the best available evidence and experience. It does this work by:
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
August 6, 2020
Reforming States Group State Health Policy Leadership Health Care Consolidation
Charles Milligan Read Bio
Back to The Milbank Blog
The pursuit of value over volume remains an epic quest in health care. Motivated to discourage overutilization of services, and by the importance of improving health outcomes through incentives for prevention and evidence-based care, purchasers continue to experiment with value-based contracting models.
Into this context comes an article in The Milbank Quarterly by Scott Greer and colleagues that argues strategic purchasing of health care services is doomed to fail. The authors reason that insurers cannot succeed because of asymmetry in four ways: insurers lack sufficient information to distinguish “value” among providers; the political system protects low-performing providers and undercuts market discipline by propping up those providers; insurers lack power at the local level to move volume to high-performing providers; and purchasers’ financial power is weak and lacks adequate clout to change providers’ behavior.
The authors conclude that rather than rely on insurers to improve health system performance, it is better to return “to the long-standing foci of health care policy studies: professionals, hospitals, voters, and politicians.” But I’m not quite ready to give up on strategic purchasing in the United States.
Let’s start with the obvious: as a higher percentage of individuals age into Medicare or enroll in Medicaid than enroll in commercial insurance, governments themselves have turned to insurers as proxies to impose discipline on providers’ utilization patterns and delivery of quality care. Administrators of governmental programs—hired by voters and politicians—long ago recognized their limited ability to contain costs when disgruntled providers enlist legislators or other elected officials to contravene those administrators’ actions.
That’s why, at least in the United States, the clear trend is to outsource those accountabilities to private entities. Yes, strategic purchasing might not pay providers different rates for the same service based on perceived quality, but strategic purchasing can mean value-added (and strategic) blocking and tackling through efforts like prior authorization and credentialing.
But there’s an even deeper issue: we can’t declare strategic purchasing ineffective without defining the value proposition we’re evaluating in the first place. The authors define strategic purchasing as “active, evidence-based engagement in defining the service mix and volume, and selecting the provider mix in order to maximize societal objectives” (emphasis added).
Thus, before pronouncing strategic purchasing ineffective, we need to define the objectives we’re trying to maximize. I’ll follow the authors’ lead and focus on Medicare.
As measured by the STAR rating system, which is a proxy for quality and includes metrics related to evidence-based care, member satisfaction, and members’ perception of their health status, strategic purchasing in the Medicare Advantage program is consistently improving over time, with the percentage of individuals enrolled in plans earning four or more stars growing from 62% to 78% between 2015 and 2020:
In addition, Medicare Advantage members receive numerous supplemental benefits not offered in original fee-for-service Medicare, and many of these benefits, such as oral health, food, fitness and gym memberships, and in-home support for disabilities, are correlated with avoidance of unnecessary medical services.
Not surprisingly, with better quality and supplemental benefits, take-up in Medicare Advantage has grown, from 13% of all Medicare beneficiaries in 2005 to 36% of beneficiaries in 2020:
In short, if the goal of Medicare Advantage plans as a strategic purchasing tool is to maximize quality, supplemental benefits, and perceived value as measured by enrollment decisions, then Medicare Advantage has been successful.1
For better or worse, one of the societal objectives that US health policy promotes is choice. Individuals want options, and not just among providers, but also among insurers. Medicare Advantage was designed to offer choice and encourage consumers to discern among the options based on benefits, STAR ratings, provider networks, and other factors. The average Medicare beneficiary now can choose from among 28 Medicare Advantage plans. If success is measured by choice, Medicare Advantage is an unequivocal success.
It is this degree of choice, perhaps more than anything, that confounds strategic purchasing:
In most strategic purchasing discussions, a key goal is to obtain provider “buy-in.” Various strategies are used, including shared savings and quality incentives, so the provider has “skin in the game.”
We’ve seen that not only do providers increasingly accept these goals, but they also want to displace insurers and directly hold the contracts with payers (i.e., government agencies and employers). Simultaneously, insurers want to become providers and drive outcomes directly, rather than through arms-length contracts with independent providers. This has resulted in provider-sponsored plans; providers and insurers merging (e.g., CVS/Aetna); and insurers buying providers (e.g., UnitedHealthcare’s growth in its Optum unit). Although these consolidations sometimes increase overall costs, they often better align incentives as well.
Greer and colleagues set up a somewhat false dichotomy between insurers and providers—as buyers and sellers of medical services, respectively—but these distinctions are losing their meaning. That, in itself, is evidence that strategic purchasing is succeeding, to better align and integrate insurers and providers.
It all comes back to what we mean when we talk about “societal objectives.” If the goal is better health, are we making progress? On that score, the results are mixed.
For one thing, it’s clear that health is dictated by many factors outside of medical care: social and environment factors, health equity and disparities, individual behavior, genetics, and poverty collectively impact health more than any clever purchasing scheme. The coronavirus pandemic has demonstrated the profound importance of public health and health equities on health.
We shouldn’t judge insurers as deficient for failing to “strategically purchase” solutions to health equity or poverty from providers. So, if Greer and colleagues’ thesis is that we should attend to the political and social power framework to focus more on public health and equity, and less on insurance, then perhaps we’re in agreement after all.
Charles Milligan is a former Medicaid director in two states and former CEO of UnitedHealthcare’s Community Plan of New Mexico.
1The same trends in expansion of managed care, value-added benefits, and attention to quality and outcomes are also true in Medicaid. See Hinton E, Rudowitz R, Diaz M, Singer N. 10 Things to Know About Medicaid Managed Care. Washington, DC: Kaiser Family Foundation; 2019. https://www.kff.org/medicaid/issue-brief/10-things-to-know-about-medicaid-managed-care/ Accessed August 6, 2020.
Nov 23, 2020
Oct 27, 2020
Oct 19, 2020
Get the Latest from the Milbank Memorial Fund
An endowed operating foundation that engages in nonpartisan analysis, collaboration, and communication, with an emphasis on state health policy.